Innovating Works

BFS

Financiado
BIONIC FEEDBACK SYSTEM FOR AMPUTEES AND DIABETICS
The BIONIC FEEDBACK SYSTEM. The Austrian company SAPHENUS Medical Technology, founded in 2016, has set itself the goal of improving the quality of people who lack the feeling in the legs, whether through polyneuropathy or through... The BIONIC FEEDBACK SYSTEM. The Austrian company SAPHENUS Medical Technology, founded in 2016, has set itself the goal of improving the quality of people who lack the feeling in the legs, whether through polyneuropathy or through amputation. 1,5 million amputees and 7,5 million people with polyneuropathy and serious sensory problems are affected all over Europe. For these two target groups SAPHENUS has the breakthrough solution using the bionic principle. With the Bionic Feedback System (BFS) the affected persons get back the feeling of the lost or damaged foot, they feel authentic again, and the brain is provided with sensory information again. SURALIS and CUTANEUS, the two BFS-products of SAPHENUS are patented high-tec add-on devices that consist of (i) a sensor sole and (ii) a transmission part which is applied on the stump or leg. SURALIS and CUTANEUS represent a new medical product category supporting cost-efficient, affordable, optimised care for amputees and diabetics. SAPHENUS has a strong network in medical research as well as in health insurances and in distribution partners. The SME-Instrument phase 1 business plan shall now be further implemented. The phase 2 workplan foresees a duration of 24 months and requests 1,8 mio of EC funding. ver más
31/08/2022
3M€
Duración del proyecto: 24 meses Fecha Inicio: 2020-08-28
Fecha Fin: 2022-08-31

Línea de financiación: concedida

El organismo H2020 notifico la concesión del proyecto el día 2022-08-31
Línea de financiación objetivo El proyecto se financió a través de la siguiente ayuda:
Presupuesto El presupuesto total del proyecto asciende a 3M€
Líder del proyecto
SAPHENUS MEDICAL TECHNOLOGY GMBH No se ha especificado una descripción o un objeto social para esta compañía.
Perfil tecnológico TRL 4-5